Alvogen, Inc recalls Levothyroxine Sodium Tablets
- Published
- 21 Jan 2026
- Agency
- FDA
- Country
- United States
The hazard
Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10.
- Brand / company
- Alvogen, Inc
- Codes / lots
- Lot # MHA21825, Exp Date: December 31, 2027
- Distribution
- US Nationwide.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 21 Jan 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.